Caillé G, du Souich P, Besner J G, Gervais P, Vézina M
Pharmacology Department, Faculty of Medicine, Université de Montréal, Quebec, Canada.
Am J Med. 1989 Jun 9;86(6A):38-44. doi: 10.1016/0002-9343(89)90155-1.
Compliance to nonsteroidal anti-inflammatory drug therapy can be compromised by gastrointestinal side effects. To overcome this problem, food, antacid, or sucralfate are often co-administered with nonsteroidal anti-inflammatory drugs. Three studies were conducted on three groups of 12 volunteers in order to determine the influence of food or sucralfate on the pharmacokinetics of naproxen and ketoprofen. In a crossover experimental design, the first group received a single dose (50 mg) of ketoprofen with and without sucralfate (2 g). The second group received single (100 mg) and multiple (100 mg twice daily for 5 days) doses of enteric-coated ketoprofen with and without food. The third group received single (500 mg) and multiple (500 mg twice daily) doses of naproxen with and without sucralfate. Multiple blood samples were drawn and analyzed by high-pressure liquid chromatography. Short- and long-term pharmacokinetic parameters were determined. Results in group 1 showed that neither ketoprofen bioavailability nor maximal plasma concentration and time to reach maximal concentration were affected by the administration of sucralfate. However, in group 2 absorption of ketoprofen was markedly affected by food. In the presence of food, maximal plasma concentration decreased from 10.7 to 6.3 micrograms/ml after single-dose administration and 12.1 to 8.0 micrograms/ml after multiple-dose administration. The time to reach maximal plasma concentration was also modified by food, increasing from 2.8 to 7.1 hours after single-dose and 2.8 to 7.6 hours after multiple-dose administration. Food caused a significant decrease in the bioavailability of ketoprofen (over 40 percent) following both single-dose (23.8 versus 13.1 micrograms.hour/ml) and multiple-dose (29.3 versus 16.8 micrograms.hour/ml) administration. Results obtained in group 3 showed that sucralfate reduced the absorption rate constant of naproxen, from 1.7 to 1.2 hours-1 and from 1.5 to 0.7 hour-1 following single- and multiple-dose administration, respectively. However, bioavailability of naproxen was not affected by sucralfate administration. Overall, these studies have shown that sucralfate does not alter the pharmacokinetics of naproxen and ketoprofen; the amount of drug absorbed remains constant. However, plasma concentrations of ketoprofen after single- and multiple-dose administration were greatly affected by food, with a decrease of greater than 40 percent in bioavailability.
非甾体抗炎药治疗的依从性可能会因胃肠道副作用而受到影响。为克服这一问题,食物、抗酸剂或硫糖铝常与非甾体抗炎药联合使用。对三组各12名志愿者进行了三项研究,以确定食物或硫糖铝对萘普生和酮洛芬药代动力学的影响。在交叉实验设计中,第一组接受单剂量(50毫克)酮洛芬,分别加用和不加用硫糖铝(2克)。第二组接受单剂量(100毫克)和多剂量(每日两次,每次100毫克,共5天)肠溶包衣酮洛芬,分别加用和不加用食物。第三组接受单剂量(500毫克)和多剂量(每日两次,每次500毫克)萘普生,分别加用和不加用硫糖铝。采集多份血样并通过高压液相色谱法进行分析。测定短期和长期药代动力学参数。第一组的结果表明,硫糖铝的给药对酮洛芬的生物利用度、最大血浆浓度及达到最大浓度的时间均无影响。然而,在第二组中,食物对酮洛芬的吸收有显著影响。在有食物的情况下,单剂量给药后最大血浆浓度从10.7微克/毫升降至6.3微克/毫升,多剂量给药后从12.1微克/毫升降至8.0微克/毫升。达到最大血浆浓度的时间也因食物而改变,单剂量给药后从2.8小时增至7.1小时,多剂量给药后从2.8小时增至7.6小时。食物使单剂量(23.8对13.1微克·小时/毫升)和多剂量(29.3对16.8微克·小时/毫升)给药后酮洛芬的生物利用度显著降低(超过40%)。第三组的结果表明,硫糖铝降低了萘普生的吸收速率常数,单剂量和多剂量给药后分别从1.7小时-1降至1.2小时-1和从1.5小时-1降至0.7小时-1。然而,硫糖铝的给药对萘普生的生物利用度没有影响。总体而言,这些研究表明,硫糖铝不会改变萘普生和酮洛芬的药代动力学;吸收的药物量保持不变。然而,单剂量和多剂量给药后酮洛芬的血浆浓度受食物的影响很大,生物利用度降低超过40%。